Sept 26 (Reuters) - Shares of BioAge Labs (BIOA.O), opens new tab opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer against the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. BioAge Labs, Inc. (NASDAQ:BIOA) is one ...

The drugs Wegovy from Novo Nordisk and Zepbound from Eli Lilly both limit appetite by targeting GLP-1 receptors in the pancreas. Global sales of GLP-1 drugs are expected to reach $95 billion annually ...

Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.

BioAge Labs, Inc. ("BioAge"), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced the ...

As a rule, clinical-stage biotech companies are high-risk investments. But they aren't all the same. The more positive clinical trial results they have for their candidates, the less speculative they ...

BioAge Labs Inc, a biotech focused on developing therapies for metabolic diseases, filed an SEC filing to raise up to $100 million in an initial public offering. The company was founded in 2015 and ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its ...

BioAge now offering 10.5 mln shares, vs 7.5 mln earlier Sofinnova expected to invest up to $1.4 mln in IPO Investment firm expected to buy shares worth $10.6 mln in private placement Sept 25 (Reuters) ...

It has only been a few weeks since BioAge made its Nasdaq debut via a $198 million IPO, and it has already suffered a setback with its main drug candidate. The Richmond, California-based start-up has ...